⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TENX News
Tenax Therapeutics, Inc.
Form 8-K
sec.gov
TENX
Tenax Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
globenewswire.com
TENX
Tenax Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
TENX
Form 8-K
sec.gov
TENX
Tenax Therapeutics Announces Late-Breaking Presentation of LEVEL Clinical Trial Data at ESC Congress 2026
globenewswire.com
TENX
Form 8-K
sec.gov
TENX
Form 8-K
sec.gov
TENX
Form 8-K
sec.gov
TENX
Form 8-K
sec.gov
TENX
Tenax Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
globenewswire.com
TENX